Free Trial

Rep. Robert Bresnahan, Jr. Sells Oracle Co. (NYSE:ORCL) Shares

Oracle logo with Computer and Technology background

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Oracle Co. NYSE: ORCL. In a filing disclosed on May 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Oracle stock on April 8th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/17/2025.
  • Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/16/2025.
  • Sold $1,001 - $15,000 in shares of Western Digital NASDAQ: WDC on 4/11/2025.
  • Sold $1,001 - $15,000 in shares of Western Digital NASDAQ: WDC on 4/10/2025.
  • Sold $1,001 - $15,000 in shares of DexCom NASDAQ: DXCM on 4/8/2025.
  • Sold $1,001 - $15,000 in shares of Invesco NYSE: IVZ on 4/8/2025.
  • Sold $1,001 - $15,000 in shares of Generac NYSE: GNRC on 4/8/2025.
  • Sold $15,001 - $50,000 in shares of Occidental Petroleum NYSE: OXY on 4/8/2025.
  • Sold $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 4/8/2025.
  • Sold $1,001 - $15,000 in shares of QUALCOMM NASDAQ: QCOM on 4/8/2025.

Oracle Stock Down 0.1%

ORCL traded down $0.12 during midday trading on Friday, reaching $150.18. 4,698,183 shares of the company were exchanged, compared to its average volume of 9,455,271. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81. The company's fifty day moving average price is $142.12 and its 200 day moving average price is $162.87. The company has a market cap of $420.05 billion, a price-to-earnings ratio of 36.72, a price-to-earnings-growth ratio of 3.46 and a beta of 1.27. Oracle Co. has a one year low of $114.55 and a one year high of $198.31.

Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings data on Monday, March 10th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts' consensus estimates of $1.49 by ($0.02). The company had revenue of $14.13 billion for the quarter, compared to the consensus estimate of $14.40 billion. Oracle had a return on equity of 133.25% and a net margin of 21.16%. The business's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.41 earnings per share. As a group, analysts expect that Oracle Co. will post 5 EPS for the current year.

Oracle Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th were issued a dividend of $0.50 per share. This is a positive change from Oracle's previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend was Thursday, April 10th. Oracle's payout ratio is currently 46.95%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Evercore ISI cut their target price on Oracle from $200.00 to $185.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 11th. Stephens assumed coverage on Oracle in a research note on Wednesday, March 19th. They issued an "equal weight" rating and a $167.00 target price on the stock. Guggenheim restated a "buy" rating and issued a $220.00 target price on shares of Oracle in a research note on Thursday, April 3rd. Barclays cut their target price on Oracle from $212.00 to $202.00 and set an "overweight" rating on the stock in a research note on Tuesday, March 11th. Finally, Piper Sandler restated a "neutral" rating and issued a $130.00 target price (down previously from $190.00) on shares of Oracle in a research note on Wednesday, April 23rd. Fourteen analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $174.42.

Get Our Latest Stock Report on ORCL

Insider Activity at Oracle

In related news, Director Naomi O. Seligman sold 2,866 shares of the stock in a transaction on Monday, May 5th. The stock was sold at an average price of $149.53, for a total value of $428,552.98. Following the transaction, the director now owns 31,764 shares of the company's stock, valued at $4,749,670.92. This represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Leon E. Panetta sold 17,500 shares of the stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $151.24, for a total value of $2,646,700.00. Following the completion of the transaction, the director now directly owns 58,090 shares in the company, valued at approximately $8,785,531.60. This represents a 23.15% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 27,366 shares of company stock valued at $4,015,723 over the last 90 days. 42.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Headlands Technologies LLC bought a new position in shares of Oracle in the first quarter worth $58,000. Blue Barn Wealth LLC increased its stake in Oracle by 15.4% in the first quarter. Blue Barn Wealth LLC now owns 5,330 shares of the enterprise software provider's stock valued at $745,000 after acquiring an additional 710 shares during the last quarter. Altfest L J & Co. Inc. increased its stake in Oracle by 18.3% in the first quarter. Altfest L J & Co. Inc. now owns 18,350 shares of the enterprise software provider's stock valued at $2,565,000 after acquiring an additional 2,835 shares during the last quarter. VeraBank N.A. increased its stake in Oracle by 9.2% in the first quarter. VeraBank N.A. now owns 10,944 shares of the enterprise software provider's stock valued at $1,530,000 after acquiring an additional 918 shares during the last quarter. Finally, Chicago Partners Investment Group LLC increased its stake in Oracle by 5.2% in the first quarter. Chicago Partners Investment Group LLC now owns 20,655 shares of the enterprise software provider's stock valued at $3,085,000 after acquiring an additional 1,022 shares during the last quarter. Institutional investors own 42.44% of the company's stock.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

Oracle Company Profile

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Articles

Should You Invest $1,000 in Oracle Right Now?

Before you consider Oracle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.

While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
Google’s $32B Move: 3 Cybersecurity Stocks to Watch
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines